healthcare

Big Step Forward in HER2-Positive Breast Cancer Trial

Seattle Genetics Inc. (NASDAQ: SGEN) shares jumped on Monday after the firm announced positive results from its midstage breast cancer trial. Specifically, Seattle Genetics announced positive topline results from the ...
Read Full Story »

Opioid Crisis Has Cost US Economy $631 Billion

In the four-year period between 2015 and 2018, opioid abuse cost the U.S. economy at least $631 billion. The human cost between 1999 and 2017 totaled nearly 400,000 lives lost. ...
Read Full Story »

A Crucial Major Depressive Disorder Study Is About to Be Underway

After Axsome Therapeutics Inc. (NASDAQ: AXSM) announced that it has completed patient enrollment in its Gemini study, a Phase 3 trial of AXS-05 in patients with major depressive disorder (MDD), ...
Read Full Story »

Are Shareholders Getting Enough in the Achillion Acquisition?

Achillion Pharmaceuticals Inc. (NASDAQ: ACHN) shares skyrocketed on Wednesday morning after an announcement that the firm would be acquired by Alexion Pharmaceuticals Inc. (NASDAQ: ALXN). While shares are up sharply ...
Read Full Story »

Why This Neuromuscular Disorder Study Could Be the Next Big Thing

Reata Pharmaceuticals Inc. (NASDAQ: RETA) shares jumped on Tuesday after the firm announced positive results from its midstage neuromuscular disorder drug trial. Specifically, the results are from Reata’s MOXIe Phase ...
Read Full Story »

Johnson & Johnson Offers a Strong Start to Earnings Season

When Johnson & Johnson (NYSE: JNJ) reported its most recent quarterly results before the markets opened on Tuesday, the pharmaceutical giant said it had $2.12 in earnings per share (EPS) ...
Read Full Story »

UnitedHealth Helps Save the Dow With Q3 Earnings

When UnitedHealth Group Inc. (NYSE: UNH) reported its third-quarter financial results before the markets opened on Tuesday, the Minnesota-based health care giant said that it had $3.88 in earnings per ...
Read Full Story »

What to Watch in the UnitedHealth Earnings Report Tuesday

UnitedHealth Group Inc. (NYSE: UNH) is set to release its third-quarter financial results before the markets open on Tuesday. Consensus estimates call for $3.75 in earnings per share (EPS) and ...
Read Full Story »

What to Expect When Johnson & Johnson Reports Tuesday

Johnson & Johnson (NYSE: JNJ) is scheduled to report its most recent quarterly results before the markets open on Tuesday. The consensus estimates are calling for $2.00 in earnings per ...
Read Full Story »

Breathalyzer to Detect Marijuana Use Ramping Up Production

Tests for marijuana use depend on a sample (urine, blood, saliva, hair), and the results of those tests indicate historical marijuana use. A small company in Oakland, California, has developed ...
Read Full Story »

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Allergan PLC (NYSE: AGN) finally has announced that its shareholders have voted to approve the company’s acquisition by AbbVie Inc. (NYSE: ABBV). The acquisition is expected to close in early ...
Read Full Story »

New Osteoarthritis Treatment Has to Wait Even Longer for FDA Approval

Flexion Therapeutics Inc. (NASDAQ: FLXN) has announced that the U.S. Food and Drug Administration (FDA) informed the company that it needs additional time to complete the review of the supplemental ...
Read Full Story »

Jefferies Not as High on Cannabis Stocks Now: Ratings and Price Target Cuts

For years, the general consensus on Wall Street is marijuana would never be legalized. Then the overall attitude started to change and laws gradually are changing. Legalization in Canada and ...
Read Full Story »

Why Hexo Is Making the Cannabis Industry Go Up in Smoke

Cannabis stocks took a big hit on Thursday after Hexo Corp. (NYSE: HEXO) gave an update on its fourth-quarter and full-year guidance. About a year ago, cannabis stocks saw a ...
Read Full Story »

Are Shareholders Getting Enough From the Ra Pharma Acquisition?

Ra Pharmaceuticals Inc. (NASDAQ: RARX) shares more than doubled on Thursday after the announcement that UCB would acquire the firm. The boards of directors of both companies have unanimously approved ...
Read Full Story »